Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |